Dimachkie , M. M., Hanna , M., Machado, P. ., Herbelin, L. ., Pasnoor, M. ., Jawdat, O., McVey , A. ., Statland, J. ., Glenn, M. D., Greensmith , L. ., Martens , B. ., Tawil, R. ., McDermott, M. ., & Barohn, R. J. (2021). Phase II Study of Arimoclomol in IBM FDA-OOPD . RRNMF Neuromuscular Journal, 2(3), 104-142. https://doi.org/10.17161/rrnmf.v2i3.15728